Trichinella spiralis Infection Suppressed Gut Inflammation with $CD4^+CD25^+Foxp3^+$ T Cell Recruitment
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
In order to know the effect of pre-existing Trichinella spiralis infection on experimentally induced intestinal inflammation and immune responses, we induced colitis in T. spiralis-infected mice and observed the severity of colitis and the levels of Th1, Th2, and regulatory cytokines and recruitment of CD4+CD25+Foxp3+ T (regulatory T; Treg) cells. Female C57BL/6 mice were infected with 250 muscle larvae; after 4 weeks, induction of experimental colitis was performed using 3% dextran sulfate sodium (DSS). During the induction period, we observed severity of colitis, including weight loss and status of stool, and evaluated the disease activity index (DAI). A significantly low DAI and degree of weight loss were observed in infected mice, compared with uninfected mice. In addition, colon length in infected mice was not contracted, compared with uninfected mice. We also observed a significant increase in production of pro-inflammatory cytokines, IL-6 and IFN-γ, in spleen lymphocytes treated with DSS; however, such an increase was not observed in infected mice treated with DSS. Of particular interest, production of regulatory cytokines, IL-10 and transforming growth factor (TGF)-β, in spleen lymphocytes showed a significant increase in mice infected with T. spiralis. A similar result was observed in mesenteric lymph nodes (MLN). Subsets of the population of Treg cells in MLN and spleen showed significant increases in mice infected with T. spiralis. In conclusion, T. spiralis infection can inhibit the DSS-induced colitis in mice by enhancing the regulatory cytokine and Treg cells recruitment.
Abstract
In order to know the effect of pre-existing Trichinella spiralis infection on experimentally induced intestinal inflammation and immune responses, we induced colitis in T. spiralis-infected mice and observed the severity of colitis and the levels of Th1, Th2, and regulatory cytokines and recruitment of CD4+CD25+Foxp3+ T (regulatory T; Treg) cells. Female C57BL/6 mice were infected with 250 muscle larvae; after 4 weeks, induction of experimental colitis was performed using 3% dextran sulfate sodium (DSS). During the induction period, we observed severity of colitis, including weight loss and status of stool, and evaluated the disease activity index (DAI). A significantly low DAI and degree of weight loss were observed in infected mice, compared with uninfected mice. In addition, colon length in infected mice was not contracted, compared with uninfected mice. We also observed a significant increase in production of pro-inflammatory cytokines, IL-6 and IFN-γ, in spleen lymphocytes treated with DSS; however, such an increase was not observed in infected mice treated with DSS. Of particular interest, production of regulatory cytokines, IL-10 and transforming growth factor (TGF)-β, in spleen lymphocytes showed a significant increase in mice infected with T. spiralis. A similar result was observed in mesenteric lymph nodes (MLN). Subsets of the population of Treg cells in MLN and spleen showed significant increases in mice infected with T. spiralis. In conclusion, T. spiralis infection can inhibit the DSS-induced colitis in mice by enhancing the regulatory cytokine and Treg cells recruitment.
참고문헌 (30)
- Motomura Y, "Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis", Clin Exp Immunol, 155, pp.88~95 (2009)
- Podolsky DK, "Inflammatory bowel disease", N Engl J Med, 347, pp.417~429 (2002)
- Moreels TG, "The hygiene hypothesis and inflammatory bowel diseases: role of helminths", Acta Gastroenterol Belg, 69, pp.413~417 (2006)
- Fiocchi C, "Inflammatory bowel disease: Etiology and pathogenesis", Gastroenterology, 115, pp.182~205 (1998)
- Wang LJ, "Helminth infections and intestinal inflammation", World J Gastroenterol, 14, pp.5125~5132 (2008)
- Ruyssers NE, "Worms and the treatment of inflammatory bowel disease: Are molecules the answer?", Clin Dev Immunol, 2008, pp.567314~ (2008)
- Summers RW, "Trichuris suis therapy in Crohn’s disease", Gut, 54, pp.87~90 (2005)
- Summers RW, "Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease", Am J Gastroenterol, 98, pp.2034~2041 (2003)
- Jasmer DP, "Trichinella spiralis infected skeletal muscle cells arrest in G2", M and cease muscle gene expression, 1993, pp.121, 785~793
- Despommier D, "Trichinella spiralis: Growth of the intracellular (muscle) larva", Exp Parasitol, 37, pp.108~116 (1975)
- "Trichinella spiralis: Infection reduces airway allergic inflammation in mice", EXPERIMENTAL PARASITOLOGY, 127(2), pp.539~544 (2011), ACADEMIC PRESS INC ELSEVIER SCIENCE
- Wirtz S, "Mouse models of inflammatory bowel disease", Adv Drug Deliv Rev, 59, pp.1073~1083 (2007)
- Wirtz S, "Chemically induced mouse models of intestinal inflammation", Nat Protoc, 2, pp.541~546 (2007)
- Perše M, "Dextran sodium sulphate colitis mouse model: traps and tricks", J Biomed Biotechnol, 2012, pp.718617~ (2012)
- Yan Y, "Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis", PLoS One, 4, pp.e6073~ (2009)
- "Alteration of helper T-cell related cytokine production in splenocytes during Trichinella spiralis infection", veterinary parasitology, 186(3-4), pp.319~327 (2012), elsevier science bv
- "Inhibition of dextran sulfate sodium (DSS)-induced intestinal inflammation via enhanced IL-10 and TGF-beta production by galectin-9 homologues isolated from intestinal parasites", MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 174, pp.53~61 (2010), Blackwell Publishing Ltd
- Nishitani Y, "Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice", Int Immunopharmacol, 9, pp.1444~1451 (2009)
- Murthy S, "RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis", Inflamm Res, 51, pp.522~531 (2002)
- Rogler G, "Cytokines in inflammatory bowel disease", World J Surg, 22, pp.382~389 (1998)
- Owczarek D, "Biological therapy of inflammatory bowel disease", Pol Arch Med Wewn, 119, pp.84~88 (2009)
- Fiorino G, "Biological Therapy for Ulcerative Colitis: what is after anti-TNF", Curr Drug Targets, 12, pp.1433~1439 (2011)
- Hoentjen F, "Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease", World J Gastroenterol, 15, pp.2067~2073 (2009)
- Stallmach A, "Adverse effects of biologics used for treating IBD", Best Pract Res Clin Gastroenterol, 24, pp.167~182 (2010)
- Summers RW, "Novel and future medical management of inflammatory bowel disease", Surg Clin North Am, 87, pp.727~741 (2007)
- Ruyssers NE, "Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice", Inflamm Bowel Dis, 15, pp.491~500 (2009)
- Presser K, "Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity", J Immunol, 181, pp.7751~7758 (2008)
- Dunne DW, "A worm’s eye view of the immune system: Consequences for evolution of human autoimmune disease", Nat Rev Immunol, 5, pp.420~426 (2005)
- Chen W, "Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3", J Exp Med, 198, pp.1875~1886 (2003)
- Huber S, "Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells", J Immunol, 173, pp.6526~6531 (2004)